Meeting
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Managing immune-related adverse events (irAEs): A new educational resource for health care professionals (HCPs) and patients.
Authors
Laura S. Wood
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Laura S. Wood, Brianna Hoffner, Krista M. Rubin, Marianne Davies, Lisa A. Tushla, Valerie Guild, Samantha R. Guild
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Immune-related Adverse Events
Citation
J Clin Oncol 37, 2019 (suppl 8; abstr 75)
DOI
10.1200/JCO.2019.37.8_suppl.75
Abstract #
75
Poster Bd #
C9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Cardiotoxicity surveillance among patients with cancer treated with immunotherapy.
First Author: Juliana Goes Martins Fagundes
Poster
2022 ASCO Annual Meeting
Immune-related adverse events and immunotherapy efficacy in patients with cancer: A retrospective study.
First Author: Lyndsey L Prather
Poster
2021 ASCO Annual Meeting
Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.
First Author: Anna Claire Olsson-Brown
Poster
2020 ASCO Virtual Scientific Program
Impact of an immuno-oncology (IO) education/monitoring program on patient’s self-efficacy and adverse event reporting from immune checkpoint inhibitors (ICIs).
First Author: Parneet Kaur Cheema